Amyloid β protein in plasma from patients with sporadic Alzheimer's disease
- 15 September 1996
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 141 (1-2) , 65-68
- https://doi.org/10.1016/0022-510x(96)00143-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Biochemical Evidence for the Long-Tail Form (Aβ1-42/43) of Amyloid β Protein as a Seed Molecule in Cerebral Deposits of Alzheimer′s DiseaseBiochemical and Biophysical Research Communications, 1994
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Blood-Brain Barrier Transport of Circulating Alzheimer′s Amyloid βBiochemical and Biophysical Research Communications, 1993
- Genetics and molecular advances in Alzheimer's diseaseTrends in Neurosciences, 1993
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993
- Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein PrecursorScience, 1993
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Antibodies to the β‐amyloid peptide cross‐react with conformational epitopes in human fibrinogen subunits from peripheral bloodFEBS Letters, 1990
- High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin GBiochemical and Biophysical Research Communications, 1987
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984